Plymouth, MI – May 23, 2022 – Phenomics Health Inc., a bioinformatics-based precision medicine company, today announced the commercial integration of six PrecīsMed® pharmacometabolomic (PMx)…
Personalized Medicine for Medication Selection and Monitoring Plymouth, MI – September 22, 2021 – Phenomics Health Inc., a platform bioinformatics-based precision medicine company, today announced…
First Integrated Pharmacogenomics and Metabolomics Platform Offers Potential to Improve Patient Outcomes, Lower Costs in Medication Therapy Ann Arbor, MI – November 14, 2019 –…
Ann Arbor, MI – January 22, 2019 – Dr. Brian D. Athey, co-founder and Chief Science & Technology Officer of Phenomics Health Inc. (PHI), presented…